Similar articles

• [The contribution of CA 19-9 in the differential diagnosis between chronic pancreatitis and cancer of the pancreas].

  Van Gossum M, Delanghe A, Gerard M, Delcourt A, Deltenre M. Van Gossum M, et al. Acta Gastroenterol Belg. 1987 Jan-Feb;50(1):91-4. Acta Gastroenterol Belg. 1987. PMID: 3480672 French. No abstract available.
• [The tumor-associated antigen CA 19-9 in the differential diagnosis and course control of malignancies of the pancreas and the gastrointestinal tract].

  Klapdor R, Greten H. Klapdor R, et al. Dtsch Med Wochenschr. 1984 Dec 14;109(50):1935-9. Dtsch Med Wochenschr. 1984. PMID: 6210188 German. No abstract available.
• [The tumor markers CA 19.9, Ca 50 and CEA in the differential diagnosis of pancreatic carcinoma].

  Röthlin M, Metzger U, Joller H, Largiadèr F. Röthlin M, et al. Schweiz Med Wochenschr. 1988 Jun 18;118(24):924-9. Schweiz Med Wochenschr. 1988. PMID: 2456610 German.
• Laboratory tests in the diagnosis of the chronic pancreatic diseases. Part 6. Differentiation between chronic pancreatitis and pancreatic cancer.

  Boyd EJ, Rinderknecht H, Wormsley KG. Boyd EJ, et al. Int J Pancreatol. 1988 May;3(4):229-40. doi: 10.1007/BF02788452. Int J Pancreatol. 1988. PMID: 3290345 Review. No abstract available.
• [Immunologic markers of pancreatic cancer in humans].

  Kulagin PP, Chalov VV. Kulagin PP, et al. Vopr Onkol. 1983;29(8):62-7. Vopr Onkol. 1983. PMID: 6193639 Review. Russian. No abstract available.